written on 04.06.2014

Out with the old, in with the new: Merck, GSK, others put established drugs on the block


Some of pharma&#39;s biggest players have already said they&#39;re looking into jettisoning their portfolios of older meds or selling off certain established products with an eye toward newer, fast-growing drugs. And as that trend takes flight, other pharma companies may look to make similar moves, <em>The Wall Street Journal</em>&#39;s sources say.